Philip Harper Insider Profile
18 Followers
Philip Harper, former Director at American Capital, holds 4.01M shares in Aevi Genomic Medicine (Ticker: ~GNMX), holds 943.51K shares in American Capital (Ticker: ACAS). Most recently, Philip Harper Bought ― shares of Aevi Genomic Medicine on Sep 06, 2017 for an estimated value of $100.53K.
Philip Harper's Trading History
| ~GNMXAevi Genomic Medicine | Sep 06, 2017 | ― | Informative Buy | 100.53K | $929.55K | |
| ACASAmerican Capital | Jan 04, 2017 | ― | Uninformative Sell | ― | $16.97M |
You May Also Like
Philip Harper insider profile FAQ
What is the percentage of profitable transactions made by Philip Harper?
The percentage of profitable transactions made by Philip Harper is 64%.
What is the average return per transaction made by Philip Harper?
The average return per transaction made by Philip Harper is 0.30%.
What stocks does Philip Harper hold?
Philip Harper holds: ACAS, ~GNMX stocks.
What was Philip Harper’s latest transaction?
Philip Harper’s latest transaction was an Informative Buy of $100.53K.
What was Philip Harper's most profitable transaction?
Philip Harper’s most profitable transaction was an Informative Buy of ~GNMX stock on March 27, 2017. The return on the trade was 22.70%.
What is Philip Harper's role in American Capital?
Philip Harper's role in American Capital is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
